ProKidney Corp. (PROK)Healthcare | Biotechnology | Winston-Salem, United States | NasdaqCM
1.61 USD
-0.15
(-8.523%) ⇩
(July 13, 2026, 4 p.m.
EDT)
|
Hot Take ↕ | July 11, 2026, 6:48 a.m. EDT
The long-term investment case is severely compromised by deteriorating fundamentals. Despite a recent price recovery, the company is burning massive cash, reporting negative operating margins of nearly -200%, and showing a sharp contraction in revenue growth (-1.7%). The balance sheet is fragile with negative book value and high debt relative to equity. While the price has rallied recently, the underlying business metrics suggest a value trap rather than a turnaround story. In the short term, there is a speculative catalyst driving the stock. The options chain reveals aggressive positioning in call options at strikes significantly above the current price, hinting at a potential binary event like a clinical trial readout or partnership announcement. However, this is a high-risk momentum play on a fundamentally broken company. The statistical forecast model offers no directional guidance, reinforcing the view that the recent price action is likely noise rather than a sustainable trend. Investors should view this as a speculative trade on a specific event, not a long-term investment in a viable biotech firm. |
| Model | MAE |
|---|---|
| AutoARIMA ✓ | 0.051787 |
| AutoETS | 0.051787 |
| AutoTheta | 0.051850 |
| MSTL | 0.056909 |
Forecast horizon: 45 days | Selected: AutoARIMA
| Forecast Reliability | |
|---|---|
| Score | 32% |
| H-stat | 0.93 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.885 |
| Excess Kurtosis | -0.35 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 1.438 |
| Revenue per Share | 0.006 |
| Market Cap | 486,316,000 |
| Forward P/E | -2.79 |
| Beta | 1.68 |
| Website | https://prokidney.com |
As of July 11, 2026, 6:48 a.m. EDT: Options activity shows a distinct bullish bias with heavy open interest in out-of-the-money calls (strikes $3.00 and $4.00) relative to puts, suggesting speculators are positioning for a significant upside move. However, implied volatility is extremely compressed (under 2% for longer-dated contracts), indicating a lack of pricing in for a major event or a 'dead cat' bounce scenario where the market expects continued stagnation.
| Attribute | Value |
|---|---|
| 52 Week Change | -0.5230352 |
| Address1 | 2,000 Frontis Plaza Boulevard |
| Address2 | Suite 250 |
| All Time High | 14.19 |
| All Time Low | 0.46 |
| Ask | 2.08 |
| Ask Size | 2 |
| Audit Risk | 8 |
| Average Daily Volume10 Day | 2,311,580 |
| Average Daily Volume3 Month | 1,118,455 |
| Average Volume | 1,118,455 |
| Average Volume10Days | 2,311,580 |
| Beta | 1.68 |
| Bid | 1.24 |
| Bid Size | 2 |
| Board Risk | 8 |
| Book Value | -7.211 |
| City | Winston-Salem |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 8 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 1.61 |
| Current Ratio | 9.059 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,782,777,600 |
| Day High | 1.75 |
| Day Low | 1.605 |
| Debt To Equity | 1.438 |
| Display Name | ProKidney |
| Earnings Timestamp | 1,778,871,600 |
| Earnings Timestamp End | 1,786,561,200 |
| Earnings Timestamp Start | 1,786,561,200 |
| Ebitda | -161,919,008 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -8.622 |
| Enterprise To Revenue | 1,570.413 |
| Enterprise Value | 1,396,097,536 |
| Eps Current Year | -0.53832 |
| Eps Forward | -0.57635 |
| Eps Trailing Twelve Months | -0.53 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 1.7968 |
| Fifty Day Average Change | -0.1868 |
| Fifty Day Average Change Percent | -0.1039626 |
| Fifty Two Week Change Percent | -52.303524 |
| Fifty Two Week High | 4.95 |
| Fifty Two Week High Change | -3.3399997 |
| Fifty Two Week High Change Percent | -0.6747474 |
| Fifty Two Week Low | 1.53 |
| Fifty Two Week Low Change | 0.08000004 |
| Fifty Two Week Low Change Percent | 0.052287612 |
| Fifty Two Week Range | 1.53 - 4.95 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,625,059,800,000 |
| Float Shares | 156,764,373 |
| Forward Eps | -0.57635 |
| Forward P E | -2.7934415 |
| Free Cashflow | -78,626,872 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 231 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,782,864,000 |
| Gross Margins | 1.0 |
| Gross Profits | 889,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.47298 |
| Held Percent Institutions | 0.244 |
| Implied Shares Outstanding | 302,059,626 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | ProKidney Corp., a clinical-stage biotechnology company, engages in the development of cell therapies for the treatment of chronic kidney diseases in the United States. The company develops rilparencel, a cell therapy with autologous selected renal cells, which is in Phase III clinical trial for the treatment of advanced chronic kidney disease and type 2 diabetes. It is also involved in the development of cryopreserved versions of rilparencel, including REGEN-006 and REGEN-008 which are both in Phase III clinical trials; REGEN-002, REGEN-003, and REGEN-007 which are in Phase II clinical trials; and REGEN-004 which is Phase I clinical trial. The company was founded in 2015 and is headquartered in Winston-Salem, North Carolina. |
| Long Name | ProKidney Corp. |
| Market | us_market |
| Market Cap | 486,316,000 |
| Market State | PRE |
| Max Age | 86,400 |
| Message Board Id | finmb_598380790 |
| Most Recent Quarter | 1,774,915,200 |
| Net Income To Common | -72,289,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 329,345,539 |
| Number Of Analyst Opinions | 6 |
| Open | 1.75 |
| Operating Cashflow | -132,209,000 |
| Operating Margins | -198.81857 |
| Overall Risk | 7 |
| Payout Ratio | 0.0 |
| Phone | 336 999 7019 |
| Pre Market Change | 0.015599966 |
| Pre Market Change Percent | 0.968942 |
| Pre Market Price | 1.6256 |
| Pre Market Time | 1,784,018,785 |
| Previous Close | 1.76 |
| Price Eps Current Year | -2.990786 |
| Price Hint | 4 |
| Price To Book | -0.22327001 |
| Price To Sales Trailing12 Months | 547.0371 |
| Profit Margins | 0.0 |
| Quick Ratio | 8.715 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.15 |
| Regular Market Change Percent | -8.52273 |
| Regular Market Day High | 1.75 |
| Regular Market Day Low | 1.605 |
| Regular Market Day Range | 1.605 - 1.75 |
| Regular Market Open | 1.75 |
| Regular Market Previous Close | 1.76 |
| Regular Market Price | 1.61 |
| Regular Market Time | 1,783,972,800 |
| Regular Market Volume | 2,043,665 |
| Return On Assets | -0.30148 |
| Return On Equity | -0.49372002 |
| Revenue Growth | -0.017 |
| Revenue Per Share | 0.006 |
| Sand P52 Week Change | 0.20847368 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 6 |
| Shares Outstanding | 205,199,713 |
| Shares Percent Shares Out | 0.0947 |
| Shares Short | 19,425,505 |
| Shares Short Previous Month Date | 1,780,012,800 |
| Shares Short Prior Month | 18,032,397 |
| Short Name | ProKidney Corp. |
| Short Percent Of Float | 0.12810001 |
| Short Ratio | 13.4 |
| Source Interval | 15 |
| State | NC |
| Symbol | PROK |
| Target High Price | 12.0 |
| Target Low Price | 1.0 |
| Target Mean Price | 6.25 |
| Target Median Price | 5.75 |
| Total Cash | 224,944,000 |
| Total Cash Per Share | 1.096 |
| Total Debt | 3,783,000 |
| Total Revenue | 889,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.53 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 2.1996 |
| Two Hundred Day Average Change | -0.58959997 |
| Two Hundred Day Average Change Percent | -0.26804873 |
| Type Disp | Equity |
| Volume | 2,043,665 |
| Website | https://prokidney.com |
| Zip | 27,103 |